Overview
- About 96% of participating Kimberly‑Clark investors and roughly 99% of Kenvue votes backed the transaction at Jan. 29 meetings.
- The proposal values Kenvue at $21.01 per share and would leave Kimberly‑Clark holders with about 54% of the combined company and Kenvue holders with about 46%.
- Management projects approximately $2.1 billion in cost and revenue synergies from the combination of household and consumer health brands.
- Both companies will operate separately until closing, and Kimberly‑Clark plans to retain its headquarters in Irving, Texas.
- Kenvue’s 2025 sales softness and KVUE trading below the offer price frame investor focus on execution and regulatory risk as integration planning begins.